Related Experiment Videos
Cost-effectiveness analysis in the treatment of hypertension: a medical view
1Dept. of Health & Family Services and St George Hospital, University of New South Wales, Australia.
Insights
Antihypertensive treatment offers significant clinical benefits, including reduced stroke and heart attack risks. While cost-effective in developed nations, its value proposition may differ in developing countries due to varying healthcare priorities and costs.
Area of Science:
- Cardiovascular Medicine
- Health Economics
- Public Health
Background:
- Hypertension management is crucial for preventing major cardiovascular events.
- Assessing the clinical and economic value of antihypertensive therapies is essential for healthcare policy.
- Quality of life considerations are important in managing chronic, often asymptomatic, conditions.
Purpose of the Study:
- To evaluate the clinical benefits and cost-effectiveness of antihypertensive treatment.
- To examine how factors like age, gender, and baseline blood pressure influence treatment value.
- To consider the implications of treatment for quality of life and its applicability in diverse economic settings.
Main Methods:
- Systematic review and meta-analysis of clinical trial data.
- Health economic modeling incorporating quality-adjusted life years (QALYs).
- Subgroup analyses based on demographic and clinical characteristics.
Main Results:
- Antihypertensive treatment significantly reduces risks of stroke, myocardial infarction, heart failure, and organ damage.
- Treatment cost-effectiveness is generally favorable in developed countries, varying with patient profiles.
- Evidence suggests neutral to slight improvements in quality of life with treatment.
- Cost-effectiveness may be less favorable in developing countries compared to other health interventions.
Conclusions:
- Antihypertensive therapy provides substantial clinical benefits and is often cost-effective in developed healthcare systems.
- Patient-specific factors influence the economic value of blood pressure management.
- The applicability and prioritization of antihypertensive treatment in developing countries require further context-specific evaluation.
Abstract:
The clinical benefits of anti-hypertensive treatment include reductions in stroke and myocardial infarction, heart failure, renal and ocular damage and possibly cognitive impairment. The cost-effectiveness of treatment generally falls within a range considered acceptable to funders of health care in developed countries, and has been shown to vary with age, gender and pre-treatment blood pressure. In a largely asymptomatic condition, small quality of life impairments resulting from treatment could offset these clinical and economic benefits, but evidence suggests that treatment is associated with slight improvements in quality of life. A limitation of these analyses is that the needs of developing countries are not met. The cost-effectiveness of anti-hypertensive treatment may be unattractive to developing countries when compared with interventions that achieve greater health gains per dollar spent.